Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02562755
Title Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Acronym PHOCUS
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors SillaJen, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | NZL | ITA | ISR | GBR | FRA | DEU | CAN | AUS


No variant requirements are available.